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Background: Findings from in vivo research may be less reliable where studies do not re-
port measures to reduce risks of bias. The experimental stroke community has been at the
forefront of implementing changes to improve reporting, but it is not known whether these
efforts are associated with continuous improvements. Our aims here were firstly to validate
an automated tool to assess risks of bias in published works, and secondly to assess the
reporting of measures taken to reduce the risk of bias within recent literature for two exper-
imental models of stroke.
Methods: We developed and used text analytic approaches to automatically ascertain re-
porting of measures to reduce risk of bias from full-text articles describing animal experi-
ments inducing middle cerebral artery occlusion (MCAO) or modelling lacunar stroke.
Results: Compared with previous assessments, there were improvements in the reporting
of measures taken to reduce risks of bias in the MCAO literature but not in the lacunar
stroke literature. Accuracy of automated annotation of risk of bias in theMCAO literature was
86% (randomization), 94% (blinding) and 100% (sample size calculation); and in the lacunar
stroke literature accuracy was 67% (randomization), 91% (blinding) and 96% (sample size
calculation).
Discussion: There remains substantial opportunity for improvement in the reporting of an-
imal research modelling stroke, particularly in the lacunar stroke literature. Further, auto-
mated tools perform sufficiently well to identify whether studies report blinded assessment
of outcome, but improvements are required in the tools to ascertain whether randomization
and a sample size calculation were reported.
Introduction
There has been much recent interest in strategies to improve the usefulness of findings from biomedical
research [1]. This has been occasioned by a growing realization that many ‘findings’ in the published
literature cannot be replicated, either in single replication attempts [2,3] or in formal replication studies
([4], https://osf.io/e81xl/wiki/home/).
There are a number of potential reasons for this, including low positive predictive values of the origi-
nator study, publication bias, heterogeneity of treatment effects due to the variable presence of unknown
modifying variables, overreliance on tests of statistical rather than biological significance and flexibility in
study protocols and statistical analysis plans. Notwithstanding these possibilities, it may be that findings
reported from laboratory research are overstated because individual studies are at risk of bias, leading to
an overstatement of treatment effects. Across the animal modelling of a range of neurological conditions
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it is apparent that studies which do not report, for instance, randomization of animals to group or the blinded assess-
ment of outcome, give inflated estimates of treatment effect [5]. Identifying the true prevalence of measures to reduce
the risk of bias is not straightforward because it may be that scientists have taken account of these measures but not,
for whatever reason, reported this in their manuscript. Recognition of this has led to the development of reporting
standards for in vivo research including the ARRIVE guidelines [6] and the Landis checklist [7].
The in vivo stroke research community have been amongst the first to adopt best practice guidelines for the conduct
and reporting of animal studies. Following the demonstration that the reporting of risks of bias in in vivo stroke
research was low [8], Good Laboratory Practice guidelines for in vivo stroke research were published in 2009 [9] and
were adopted as editorial policy by a number of Journals including ‘Stroke’. Subsequently, Minnerup et al. [10] have
shown a substantial increase in the prevalence of reported randomization of group allocation, blinded conduct of
the experiment, blinded assessment of outcome and sample size calculations in the years from 2010 to 2013. Recent
research suggests that improvement may been limited to specific journals reporting predominantly stroke research
[11]. In 2014, Pedder et al. [12] reported a systematic review of animal studies in lacunar stroke published between
1992 and 2011, where the reporting of measures to reduce risks of bias was in general better than had been observed
in the middle cerebral artery occlusion (MCAO) literature in 2007 [8]. It is not known, however whether the quality
of reporting in lacunar stroke has improved since that time Figures 1–3.
Ascertainment of improvement in reporting might serve as an important outcome measure for efforts to improve
performance at the level of a journal, funder, or institution, as part of a research improvement activity. However, one
problem with this approach is that ascertainment of reporting of measures to reduce risks of bias in published work
is a time-consuming process, requiring review of full-text by at least two independent assessors to minimize risk of
human error and taking around 1 h for each manuscript. We have therefore set out to develop text mining tools to
automatically ascertain the reporting of key measures to reduce risks of bias in published works describing animal
research modelling of MCAO and lacunar stroke.
Methods
This development work was not guided by a study protocol. Criteria for successful performance of a text mining
system were developed at a consensus meeting organized by the SLIM (Systematic Living Information Machine)
consortium in April 2016 (prior to the commencement of this project), which recommended that a tool performing
with sensitivity and specificity of at least 0.80 could make a valuable contribution.
Identiﬁcation of relevant manuscripts
ForMCAO studies, we searchedPUBMED on 4 October 2016with the terms<middle cerebral artery occlusion>OR
<MCAO>, limited to animals, with a date of record completion later than 4 October 2014. For lacunar stroke studies,
we searched PUBMED on 11 January 2017 using the terms employed in Pedder et al., limited to a deposition date
between 6 March 2012 (the date of the search which informed the Pedder review) and 11 January 2017 for the terms
((< Biological Models> OR<Animal Disease Models> OR<Animal Models> OR<Animals> OR<mammals>
OR <primates> OR <mice> OR <rats>) AND (<cerebrovascular disorders> OR <basal ganglia cerebrovascu-
lar disease> OR <brain ischemia> OR <cerebrovascular accident> OR <brain infarction> OR <brain hypoxia
ischemia> OR <brain edema> OR <cerebrovascular accident> OR <vascular dementia> OR <intracranial arte-
rial diseases> OR <intracranial vasospasm>) AND (<Stroke* [TW]> OR <cerebrovasc* [TW]> OR <cerebral
vasc* [TW]> OR <cerebral* [TW]>) AND (<micro vessel [tw]> OR <small vessel [tw]> OR <perforat* vessel
[tw]> OR <arteriole [tw]> OR <lacunar stroke [tw]> OR <lacunar infarct [tw]> OR <small stroke* [tw]> OR
<small occlusion* [tw]> OR <small disease* [tw]> OR <micro stroke* [tw]> OR <micro occlusion* [tw]> OR
<micro disease* [tw]>OR<lacun* infarct* [tw]>OR<lacun* lesion* [tw]>OR<lacun* stroke* [tw]>OR<small
infarct* [tw]>OR<small lesion* [tw]>OR<small stroke* [tw]>OR<subcortical infarct* [tw]>OR<subcortical
lesion* [tw]>OR<subcortical stroke* [tw]>OR<deep infarct* [tw]>OR<deep lesion* [tw]>OR<deep stroke*
[tw]> OR <silent infarct* [tw]> OR <silent lesion* [tw]> OR <silent stroke* [tw])) NOT (<heart [tiab]> OR
<bone [tiab]> OR<eye [tiab]> OR<lung [tiab]> OR<kidney [tiab]> OR<liver [tiab]> OR<renal [tiab]> OR
<intestine* [tiab]> OR <spinal [tiab]> OR <pulmonary [tiab]> OR <hepatic [tiab]> OR <global [tiab]> OR
<AD [tw]> OR<PD [tw]> OR<Alzheimer* [tw]> OR<Parkinson* [tw]> OR<epilepsy [tw]> OR<MS [tw]>
OR <Multiple Sclerosis [tw]), limited to animals. Each of these search results was screened by a single investigator
using the NC3Rs/CAMARADES SyRF facility (app.syrf.org.uk) for inclusion. We also extracted the journal in which
the work was published. Full-text pdf articles were retrieved through the reference management software EndNote
X8 using our institutional full-text subscriptions, and subsequently converted to text files using PDF Extractor SDK.
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Figure 1. Reporting of risks of bias in the recent MCAO literature.
Reporting of (A) blinding, (B) randomization and (C) sample size calculation in the middle cerebral artery occlusion literature in
6-month epochs to October 2016. Values represent mean and 95% Clopper–Pearson exact confidence intervals.
Development of ‘regular expressions’
In the context of a systematic review of studies describing animalmodels of psychosis, we collected phrases associated
with the reporting of randomization, blinded assessment of outcome and sample size calculations and used these to
develop target regular expressions (“RegEx”s). These were informally tested through application to a second dataset
c© 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons
Attribution License 4.0 (CC BY).
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Figure 3. Reporting of risks of bias in the recent literature compared with previous estimates.
(A) Reporting of blinding, randomization and sample size calculation in the MCAO literature collated from systematic reviews and
summarized in 2007 in Sena et al. [8] (column 1), from the journal Stroke from 2010 to 2013 reported by Minnerup et al. [10] (column
2), and from 2014 to 2016 reported here (column 3). (B) Reporting of blinding, randomization and sample size calculation in the
experimental lacunar stroke literature from the systematic review of 2012 [12] (column 1), and from 2012 to 2017 reported here
(column 2).
of 1173 full-text publications describing in vivo research where risks of bias had been previously extracted [13], and
no changes were made. We then applied these tools to the converted full-text of stroke publications using the Grepl
function in R, resulting in a call of ‘true’ or ‘false’ for each of the measures to reduce risk of bias. We then conducted
manual (‘gold standard’) ascertainment of reporting of measures to reduce risk of bias for each publication. To com-
pare the text analytic with human ‘gold standard’, we calculated sensitivity (effectiveness of the tool in identifying
positives), specificity (effectiveness of the tool in identifying negatives) and accuracy (number of publications cor-
rectly labelled as a proportion of the total number of publications).The R code is available at GitHub (link provided
on publication).
We present the prevalence of reporting of randomization of animals to experimental groups, blinded assessment
of outcome and sample size calculation, along with exact binomial confidence intervals (derived using cii in STATA)
for each dataset and, for the MCAO literature, in quartiles of PUBMED accession date and by journal. Least squares
linear regression was used to understand the correlation between time of publication and the reporting of measures
taken to reduce the risk of bias.
2528 c© 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons
Attribution License 4.0 (CC BY).
Clinical Science (2017) 131 2525–2532
https://doi.org/10.1042/CS20160722
Figure 2. Reporting of risks of bias by Journal.
Reporting of (A) blinding, (B) randomization and (C) sample size calculation in the middle cerebral artery occlusion literature in
the 2 years to October 2016 by journal of publication for journals with five or more relevant manuscripts, ranked by performance.
Values represent mean and 95%Clopper–Pearson exact confidence intervals. The grey shaded bar represents the 95% confidence
interval of the overall performance across 918 manuscripts.
c© 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons
Attribution License 4.0 (CC BY).
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Table 1 Summary of performance of RegEx compared with gold standard of manual human ascertainment
Prevalence (RegEx)
Prevalence (gold
standard) Sensitivity Speciﬁcity Accuracy
MCAO (n=918)
Randomization 73% 60% 1.00 0.67 87%
Blinding 68% 59% 0.99 0.77 90%
Sample size calculation 2% 6% 0.26 0.99 95%
Lacunar (n=46)
Randomization 67% 37% 1.00 0.48 67%
Blinding 61% 53% 1.00 0.81 91%
Sample size calculation 4% 9% 0.50 1.00 96%
Accuracy is calculated as the number of publications correctly labelled as a proportion of the total number of publications.
Results
In 2259 studies reporting animal models of psychosis, the RegEx had performed above our pre-defined performance
criteria (sensitivity of 0.80 and specificity of 0.91 for randomization, sensitivity of 0.83 and specificity of 0.95 for
blinding, and sensitivity of 1.00 and specificity of 0.96 for sample size calculation). In a second dataset of in vivo
studies from leading U.K. institutions [13], the tool was somewhat less efficient in calling papers as randomized
(sensitivity of 1.00 and specificity of 0.62), but blinding and sample size calculation ascertainment were still above
our successful performance criteria level of 0.80 (sensitivity of 0.88 and specificity of 0.98 for blinding, and sensitivity
of 0.88 and specificity of 0.97 for sample size calculation).
For the MCAO search we identified 1311 publications, of which 1152 met our inclusion criteria. We were able to
retrieve full-text pdfs for 918 of these.
The RegEx called 670 of 918 MCAO studies (73%) as reporting randomization, 621 (68%) as reporting the blinded
assessment of outcome and 21 (2%) as reporting a sample size calculation. Compared with manual assessment, sensi-
tivity was 1.00 (randomization), 0.99 (blinding) and 0.26 (sample size calculation), with specificity of 0.67 (random-
ization), 0.77 (blinded assessment of outcome) and 0.99 (sample size calculation). Accuracywas 87% (randomization),
90% (blinded assessment of outcome) and 95% (sample size calculation) (Table 1).
Reporting of randomization and of sample size calculations was highest in the last quartile and lowest in the first
quartile, but using least squares linear regression we found no significant change over time. In journals represented
in the dataset by five publications or more, reporting of randomization ranged from 33% to 100% (median 76%),
of blinded outcome assessment from 17% to 100% (median 70%), and of sample size calculations from 0% to 17%
(median 0%).Overall, reporting of thesemeasures to reduce risk of bias showed substantial improvements from those
observed in a selection of stroke systematic reviews reported in 2007. In the 50 publications carried in the journal
Stroke, the performance in 2014–2016 was comparable with that reported from 2013 by Minnerup.
For the lacunar search we identified 492 publications, of which 61 met our inclusion criteria and of which we were
able to retrieve full-text for 46. This lower rate of inclusion (12% vs 87% for MCAO) reflects the reduced sensitivity of
the search terms used, reflecting in turn the heterogeneity in the terms used to describe animal experimentsmodelling
lacunar stroke.
The RegEx called 31 of 46 lacunar studies (67%) as reporting randomization, 28 (61%) as reporting the blinded
assessment of outcome and 2 (4%) as reporting a sample size calculation. Compared withmanual ascertainment, sen-
sitivity was 1.00 for each of randomization and blinded assessment of outcome, and 0.50 for sample size calculation,
with specificity of 0.48 (randomization), 0.81 (blinded assessment of outcome) and 1.00 (sample size calculation).
Accuracy was 67% (randomization), 91% (blinded assessment of outcome) and 96% (sample size calculation). True
prevalence of randomization was 37%, of blinding 53% and of sample size calculations 9%. These are essentially un-
changed from the Pedder review of the lacunar stroke literature up to 2012, showing no improvements in reporting
of measures to reduce risk of bias over time. No journals were represented in the dataset by five publications or more.
Discussion
There have been improvements in reporting of measures to reduce risks of bias in the MCAO literature over the
last 10 years, but we did not observe similar improvements in the in vivo lacunar stroke literature. For both MCAO
and lacunar stroke the reporting of a sample size calculation remained low, and there remains substantial room for
2530 c© 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons
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improvement. Within the MCAO literature performance differed between journals, for instance, in journals con-
tributing five or more publications the rate of reporting of randomization ranged from 33% to 100%, of blinding
from 17% to 100%, and of sample size calculation from 0% to 17%. There were no substantial differences, in aggre-
gate, in 239 manuscripts published in journals publishing fewer than five included publications compared with 679
manuscripts published in journals publishing five or more included publications (blinding 63% (less than 5) vs 69%
(5 or more), randomization 72% vs 73%, sample size calculation 1% vs 3%).
While it has been argued that an experiment not guided by a sample size calculation is not in itself at risk of bias,
we consider the presentation of a sample size calculation to give much greater confidence in the results presented.
Firstly, in the presence of publication bias, underpowered experiments will lead to a literature that overstates observed
effects [14]. Secondly, a sample size calculation gives greater confidence that the experiment is presented as originally
planned, rather than group size being incrementally increased until an arbitrary level of statistical significance is
achieved. Finally, the positive predictive value of an experiment is increased when a study has adequate statistical
power [15], and without a sample size calculation this is less likely to be the case.
Our study has limitations. Firstly, screening and gold standard risk of bias annotations were performed by a single
investigator, and this may have led to errors. Secondly, we were only able to perform data extraction for manuscripts
where full-text pdf was available for automated retrieval or pdf could be converted to text, and it may be that the
reporting of risks of bias is different in journals for which we do not enjoy an institutional subscription. Moreover,
the automated tool did not take into account the existence of any supplementary materials that might have been
associated with a publication and may have contained the reporting of methodology pertaining to the measures to
reduce risk of bias. Such supplementary materials are not always returned during automatic text retrieval; but in any
case reporting guidelines usually recommend that such items be covered in the main text.
Finally, the performance of the RegEx for randomization and for sample size calculations did not perform as well
for stroke studies as had been the case in other datasets. Problems related mainly to ‘overcalling’ of blinding and
randomization (low specificity) and ‘undercalling’ of sample size calculations (low sensitivity). It may be that there
are domain specific differences in language used, and these will be incorporated into further iterations of the RegEx
used.
Future work will include the integration with text mining tools which support screening (such as app.syrf.org.uk)
and reduce the amount of annotations required by using topic analysis and active learning [16,17]; and crowdsourced
annotations performed in the context of reviews using the SyRF platform will contribute to the pool of annotated
data available for tool development.
However, for the reporting of the blinded assessment of outcome our RegEx performed at or around the levelwhich
had previously been determined as the threshold above which it could be used for the automated ascertainment of
the reporting of measures to reduce risk of bias in in vivo research. Such ascertainment, providing as it does almost
real-time reporting of the performance of a journal (or an institution, a funder or a nation),might serve as an indicator
of changes in the quality of published research, and be used to guide audit for improvement activity, for instance the
application of Plan-Do-Study-Act cycles [18] to research activity.
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